We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+34.48%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$178M
Cap. Flow
-$144M
Cap. Flow %
-8.58%
Top 10 Hldgs %
86.9%
Holding
29
New
3
Increased
5
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$66.4M
2
GMED icon
Globus Medical
GMED
+$48.1M
3
NWSA icon
News Corp Class A
NWSA
+$43.1M
4
AIV
Aimco
AIV
+$17.4M
5
CTRI icon
Centuri Holdings
CTRI
+$14.7M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$88.1M
2
SAGE
Sage Therapeutics
SAGE
+$55.4M
3
WLY icon
John Wiley & Sons Class A
WLY
+$35.6M
4
INDV icon
Indivior Pharmaceuticals
INDV
+$30.5M
5
INVX
Innovex International
INVX
+$27.6M

Sector Composition

Rank Sector Weight
1 Healthcare 42.15%
2 Industrials 17.27%
3 Technology 13.81%
4 Financials 9.85%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHC icon
1
Graham Holdings Company
GHC
$4.97B
$289M 17.27%
245,829
+558
+0.2% +$577K
SNDK
2
Sandisk
SNDK
$213B
$231M 13.81%
2,062,521
-1,508,588
-42% -$88.1M
MKL icon
3
Markel Group
MKL
$25B
$161M 9.62%
84,310
– –
INDV icon
4
Indivior Pharmaceuticals
INDV
$4.79B
$156M 9.3%
6,463,585
-1,458,593
-18% -$30.5M
GMED icon
5
Globus Medical
GMED
$10.4B
$146M 8.71%
2,548,163
+836,015
+49% +$48.1M
SOLV icon
6
Solventum
SOLV
$13.5B
$145M 8.66%
1,988,376
-255,968
-11% -$18.8M
TBPH icon
7
Theravance Biopharma
TBPH
$874M
$139M 8.29%
9,511,150
– –
LKFT
8
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$76.1M 4.54%
2,195,775
+318,764
+17% +$10.2M
BTI icon
9
British American Tobacco
BTI
$132B
$65M 3.88%
+1,223,767
New +$66.4M
WLY icon
10
John Wiley & Sons Class A
WLY
$2.52B
$47.4M 2.83%
1,170,624
-882,072
-43% -$35.6M
STGW icon
11
Stagwell
STGW
$1.84B
$45.1M 2.69%
8,014,322
– –
NWSA icon
12
News Corp Class A
NWSA
$14.5B
$44.6M 2.66%
+1,453,322
New +$43.1M
KROS icon
13
Keros Therapeutics
KROS
$199M
$42.8M 2.56%
2,708,218
+16,753
+0.6% +$247K
MAGN
14
Magnera Corp
MAGN
$488M
$33.2M 1.98%
2,832,281
-511,724
-15% -$6.35M
AIV
15
Aimco
AIV
$380M
$28.7M 1.71%
3,617,314
+2,143,488
+145% +$17.4M
CTRI icon
16
Centuri Holdings
CTRI
$2.79B
$14.7M 0.88%
+693,136
New +$14.7M
FSP
17
Franklin Street Properties
FSP
$44.8M
$4.13M 0.25%
2,580,357
– –
NNI icon
18
Nelnet
NNI
$4.79B
$3.95M 0.24%
31,535
-112,679
-78% -$14.1M
ALMS
19
Alumis Inc
ALMS
$3.57B
$1.67M 0.1%
417,777
-1,424,492
-77% -$5.87M
SN icon
20
SharkNinja
SN
$21B
$635K 0.04%
6,152
– –
ARVN icon
21
Arvinas
ARVN
$518M
– –
-500,000
Closed -$3.68M
CMCO icon
22
Columbus McKinnon
CMCO
$465M
– –
-45,961
Closed -$702K
CNNE icon
23
Cannae Holdings
CNNE
$647M
– –
-674,250
Closed -$14.1M
CRGX
24
DELISTED
CARGO Therapeutics
CRGX
– –
-4,193,626
Closed -$17.3M
OVID icon
25
Ovid Therapeutics
OVID
$435M
– –
-1,311,362
Closed -$433K
1
2

Similar funds

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
LFM
LGT Fund Management Vaduz, Liechtenstein $2.3B AUM 22.66% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
NSAM
North Star Asset Management Neenah, Wisconsin $2.31B AUM 10.09% 1-Year Est. Return
EPM
Elm Partners Management Philadelphia, Pennsylvania $2.31B AUM 16.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

Madison Avenue Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Madison Avenue Partners held 29 positions worth $1.68B, up 12% from $1.5B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Madison Avenue Partners withdrew a net $144M in Q3 2025, closing 9 positions and reducing 7 holdings. Its most notable exit was Sage Therapeutics, an estimated $55.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, Madison Avenue Partners opened a new position in British American Tobacco worth $65M.

  • Madison Avenue Partners's largest Q3 2025 buy was British American Tobacco: 1,223,767 shares worth $65M.
  • Madison Avenue Partners added most to Globus Medical in Q3 2025, an estimated $48.1M increase.
  • Madison Avenue Partners's biggest Q3 2025 reduction was Sandisk, cutting an estimated $88.1M.
  • Madison Avenue Partners fully exited Sage Therapeutics in Q3 2025, selling an estimated $55.4M.
  • Madison Avenue Partners's ten largest holdings make up 87% of its $1.68B portfolio in Q3 2025.
  • Madison Avenue Partners opened 3 new positions and closed 9 in Q3 2025.
  • Madison Avenue Partners's portfolio value rose 12% quarter-over-quarter to $1.68B.

Based on Madison Avenue Partners's 13F filing for Q3 2025, filed 14 Nov 2025.